DK0554344T3 - Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor - Google Patents

Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor

Info

Publication number
DK0554344T3
DK0554344T3 DK91919512T DK91919512T DK0554344T3 DK 0554344 T3 DK0554344 T3 DK 0554344T3 DK 91919512 T DK91919512 T DK 91919512T DK 91919512 T DK91919512 T DK 91919512T DK 0554344 T3 DK0554344 T3 DK 0554344T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
polypeptide
treating
preventing
antibody
Prior art date
Application number
DK91919512T
Other languages
English (en)
Inventor
Pierre Chambon
Marie-Paule Kieny
Richard Lathe
Mara Hareuveni
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0554344T3 publication Critical patent/DK0554344T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91919512T 1990-10-23 1991-10-23 Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor DK0554344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9013101A FR2668064B1 (fr) 1990-10-23 1990-10-23 Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
PCT/FR1991/000835 WO1992007000A1 (fr) 1990-10-23 1991-10-23 Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne

Publications (1)

Publication Number Publication Date
DK0554344T3 true DK0554344T3 (da) 1999-05-17

Family

ID=9401474

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919512T DK0554344T3 (da) 1990-10-23 1991-10-23 Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor

Country Status (12)

Country Link
US (3) US5861381A (da)
EP (1) EP0554344B1 (da)
JP (1) JP3195958B2 (da)
AT (1) ATE169640T1 (da)
CA (1) CA2094705C (da)
DE (1) DE69129989T2 (da)
DK (1) DK0554344T3 (da)
ES (1) ES2121791T3 (da)
FR (1) FR2668064B1 (da)
HK (1) HK1012841A1 (da)
SG (1) SG96535A1 (da)
WO (1) WO1992007000A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668064B1 (fr) * 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
AU671971B2 (en) * 1991-11-29 1996-09-19 Chiron Corporation Anti-cancer immunotherapeutic vector constructs
FR2751343B1 (fr) * 1996-07-16 1998-12-18 Transgene Sa Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2021000A (en) * 1998-11-03 2000-05-22 Penn State Research Foundation, The Novel nucleic acid molecules encoding opioid growth factor receptors
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
DE19917195B4 (de) 1999-04-16 2006-09-28 Immatics Biotechnologies Gmbh Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor
DE60030450T2 (de) * 1999-09-08 2007-08-30 Transgene S.A. Von MUC-1 abgeleitete Peptide
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
CN1455680A (zh) * 2000-09-11 2003-11-12 达纳-法伯癌症协会有限公司 Muc1胞外域和癌症治疗组合物及方法
US20040018181A1 (en) * 2000-09-11 2004-01-29 KUFE Donald W. MUC1 interference RNA compositions and methods derived therefrom
EP1354196B1 (en) 2000-11-27 2010-09-15 Minerva Biotechnologies Corporation Diagnostics, drug screening and treatment for cancer
AU2002246791C1 (en) * 2000-12-22 2008-04-03 Dana-Farber Cancer Institute, Inc. Regulation of cell growth by MUC1
NZ528234A (en) * 2001-04-02 2006-01-27 Univ Miami Mucin peptide with immunoenhancing properties
US6716627B2 (en) 2001-12-20 2004-04-06 Isis Pharmaceuticals, Inc. Antisense modulation of mucin 1, transmembrane expression
JP3854905B2 (ja) * 2002-07-30 2006-12-06 株式会社 日立ディスプレイズ 液晶表示装置
EP2363410B1 (en) * 2002-11-27 2017-10-11 Minerva Biotechnologies Corporation Isoforms of MUC1
US20080090770A1 (en) * 2003-04-11 2008-04-17 Belmares Michael P Modulation of Muc1 Mediated Signal Transduction
AU2004263274B2 (en) 2003-07-21 2009-11-05 Transgene S.A. Novel multifunctional cytokines
WO2005042573A1 (en) 2003-10-24 2005-05-12 Dana-Farber Cancer Institute, Inc. Modulation of the interaction of muc1 with muc1 ligands
JP5060134B2 (ja) * 2003-12-12 2012-10-31 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ ヒト細胞傷害性Ｔリンパ球のエピトープ及びそのＭＵＣ−１の非ＶＮＴＲ（ｎｏｎ−ｖａｒｉａｂｌｅｎｕｍｂｅｒｏｆｔａｎｄｅｍｒｅｐｅａｔｓｅｑｕｅｎｃｅ）由来のアゴニストエピトープ
US20070202134A1 (en) * 2004-02-23 2007-08-30 Kufe Donald W Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis
US20090317414A1 (en) * 2006-07-25 2009-12-24 4G Vaccines Pty Ltd Cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
WO2008097844A2 (en) * 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins
AU2010205717A1 (en) 2009-01-13 2010-07-22 Transgene Sa Use of a Saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
EP2382474B1 (en) 2009-01-20 2015-03-04 Transgene SA Soluble icam-1 as biomarker for prediction of therapeutic response
WO2010108908A1 (en) 2009-03-24 2010-09-30 Transgene Sa Biomarker for monitoring patients
NZ594896A (en) 2009-04-17 2013-07-26 Transgene Sa Biomarker for monitoring patients
US8445270B2 (en) 2009-05-12 2013-05-21 Transgene S.A. Immortalized avian cell lines and use thereof
RU2552292C2 (ru) 2009-07-10 2015-06-10 Трансжене Са Биомаркер для отбора пациентов и связанные с ним способы
IN2012DN01577A (da) 2009-07-21 2015-06-05 Transgene Sa
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
TWI690322B (zh) 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
WO2014066443A1 (en) 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
JP6655618B2 (ja) 2014-12-01 2020-02-26 トランジェーヌＴｒａｎｓｇｅｎｅ 安定な液体ワクシニアウイルス処方物
AU2016219350A1 (en) 2015-02-10 2017-08-24 Minerva Biotechnologies Corporation Humanized anti-MUC1* antibodies
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
WO2018069316A2 (en) 2016-10-10 2018-04-19 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
MX2020009262A (es) 2018-03-07 2021-01-08 Transgene Vectores de parapoxvirus.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707438A (en) * 1984-08-22 1987-11-17 Tel Aviv University Immunoassay for breast cancer employing monoclonal antibodies
CA1339204C (en) * 1987-01-07 1997-08-05 Joyce Taylor-Papadimitriou Mucin core polypeptide, antibodies and probes
DE10399032I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
SE459115B (sv) * 1987-10-08 1989-06-05 Gas Control Equipment Ab Anordning i ventil foer gasbehaallare
EP0442926A1 (en) * 1988-11-10 1991-08-28 Imperial Cancer Research Technology Limited Polypeptides
JPH02273195A (ja) * 1988-11-17 1990-11-07 Univ Melbourne ヒト多型性上皮ムチンと反応するモノクローナル抗体
FR2668064B1 (fr) * 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.

Also Published As

Publication number Publication date
US6203795B1 (en) 2001-03-20
FR2668064A1 (fr) 1992-04-24
WO1992007000A1 (fr) 1992-04-30
DE69129989D1 (de) 1998-09-17
ES2121791T3 (es) 1998-12-16
EP0554344A1 (fr) 1993-08-11
CA2094705A1 (fr) 1992-04-24
FR2668064B1 (fr) 1994-12-16
CA2094705C (fr) 2007-05-15
DE69129989T2 (de) 1999-04-08
US5861381A (en) 1999-01-19
HK1012841A1 (en) 1999-08-06
JP3195958B2 (ja) 2001-08-06
JPH06502399A (ja) 1994-03-17
SG96535A1 (en) 2003-06-16
ATE169640T1 (de) 1998-08-15
EP0554344B1 (fr) 1998-08-12
US6328956B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
DK0554344T3 (da) Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor
ES2113088T3 (es) Metodo de entrega de agentes a celulas diana.
FI972390A (fi) Sytokiini nimeltä Lerk-7
ATE47155T1 (de) Monoklonaler antikoerper.
DK0672063T3 (da) Mindste genkendelsesenhed af et PEM mucintandemgentagelsesspecifikt monoklonalt antistof
DE69028388D1 (de) Monoklonaler antikörper gegen ein neues humanes tumor assoziiertes antigen
FI961251A (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
PT100637A (pt) Receptor ctla4 e metodos para a sua utilizacao
MX9804358A (es) Apoptosis inducida por el anticuerpo monoclonal anti-her2.
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
DE69033735D1 (de) Varianten von adhäsionsmoleküle für blutplättchen
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
YU46189B (sh) Monoklonska antitela i antigen za karcinome pluća čoveka koji ne pripadaju tipu "malih ćelija"
ATE387458T1 (de) Fas-antigenbindender ligand
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DE69414870D1 (de) Antikoerper mit geaenderter zielrichtung
ES2173910T3 (es) Anticuerpos humanizados dirigidos contra el antigeno a33.
YU46386B (sh) Monoklonska antitela i antigeni za ljudske karcinome pluća koji ne pripadaju tipu "malih ćelija"
ATE164838T1 (de) Neue propoxyphenderivate sowie deren protein-und polypeptidlabels und-konjugate
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
DE69229573D1 (de) Monoklonaler Antikörper, Polypeptide und deren Herstellung
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
ATE92081T1 (de) Tumorassoziiertes antigen.